"The FDA did not vet the data, according to our review of emails obtained under the Freedom of Information Act and questions to FDA officials. Instead, it saw Mississippi, as one email said, as 'an opportunity to remind the public of our own warnings for ivermectin.'".
"The other question is why ivermectin is not. The FDA tweet arrived just as ivermectin prescriptions were soaring, up twenty-four-fold in August from before the pandemic."
Without reviewing the available data, which had long since been available and accumulating, it is unclear what basis the FDA had for denouncing ivermectin as a treatment or prophylaxis for COVID-19.
"The FDA has similarly charted a course of confusion. In March 2021, the FDA posted a webpage entitled 'Why You Should Not Use Ivermectin to Great or Prevent COVID-19.'".
Although the FDA's concern was stories of some people using the animal form of ivermectin or excessive doses of the human form, the title broadly condemned any use of ivermectin in connection with COVID-19.
The FDA itself acknowledged on that very webpage that the agency had not even 'reviewed data to support use of ivermectin in COVID-19 patients to treat or prevent COVID-19.'.
Peterson also highlights the fact that while the FDA claims ivermectin "Is not an antiviral," on another FDA webpage they list a study in Antiviral Research that "Identified ivermectin as a medicine 'previously shown to have broad-spectrum antiviral activity."
https://noqreport.com/2021/10/25/secret-documents-reveal-fdas-attack-on-ivermectin/
No comments:
Post a Comment